Alzheimer’s disease and Parkinson’s disease are two of the most commonly discussed neurodegenerative diseases that affect the elderly population. Alzheimer’s is a progressive degenerative brain disorder that affects memory, thinking, behavior and other cognitive functions, whereas Parkinson’s affects the nervous system, causing difficulty with movement, including trembling, difficulty walking and trembling. The exact cause of Alzheimer’s and Parkinson’s diseases is not known, although genetics and environmental factors are thought to play roles in their development. In particular, research has shown that Alzheimer’s is likely passed on through familial history, and environmental factors, such as highly toxic exposure, are connected to cases of Parkinson’s. Other medical conditions such as diabetes, high blood pressure, and high cholesterol, have been found to increase the risk of developing either Alzheimer’s or Parkinson’s. Though the causes of these diseases are not yet fully understood, scientists are continuing to investigate potential treatments and preventive measures. For Alzheimer’s, current treatments aim to slow down the progression of the disease, while those for Parkinson’s have focused on alleviating symptoms. Scientists have also been looking into ways of preventing and delaying the onset of both diseases. The Alzheimer’s Association has currently identified risk reduction strategies, which include healthier eating, exercise, mental stimulation, and proper management of medical conditions such as hypertension and diabetes. As medical technology advances, more research is being conducted to better understand Alzheimer’s and Parkinson’s diseases, and to find possible treatments for them. Both diseases share many of the same risk factors, and progress differently for each individual.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A Case Report
George Diaz, Memorial Healthcare Systems, United States
Title : What we don’t know about hydrocephalus and It’s management
Daniel Curry, Texas Children’s Hospital, United States
Title : Artificial intelligence-driven DWI and FLAIR for the detection of early stroke changes: A systematic review
Shari L Guerra, The Medical City, Philippines
Title : Mapping neuroplasticity in occupational therapy: Evidence-based interventions with measurable neural outcomes
Jessica Marchant, Texas Woman's University, United States
Title : Non-pharmacologic management of orthostatic hypotension in inpatient rehabilitation: A quality improvement initiative
Laura Steakin, Rehabilitation Institute at Sinai, United States
Title : Non-pharmacologic management of orthostatic hypotension in inpatient rehabilitation: A quality improvement initiative
Mackenzie Weber, Rehabilitation Institute at Sinai, United States